Results 61 to 70 of about 9,382 (207)
Immunity, Inflammation and Disease, Volume 13, Issue 9, September 2025.Low thoracic muscle mass is associated with adverse outcomes in patients with severe fever with thrombocytopenia syndrome. Thoracic muscle mass may serve as a reliable prognostic marker for severe fever with thrombocytopenia syndrome in clinical settings.
Xiao‐Min Wang +7 more
wiley +1 more source
Outbreak of Hantavirus Pulmonary Syndrome, Los Santos, Panama, 1999–2000
Emerging Infectious Diseases, 2004 An outbreak of hantavirus pulmonary syndrome occurred in the province of Los Santos, Panama, in late 1999 and early 2000. Eleven cases were identified; 9 were confirmed by serology. Three cases were fatal; however, no confirmed case-patient died.
Vicente Bayard +21 more
doaj +1 more source
Complex evolution and epidemiology of Dobrava-Belgrade hantavirus: definition of genotypes and their characteristics. [PDF]
, 2013 Dobrava-Belgrade virus (DOBV) is a human pathogen that has evolved in, and is hosted by, mice of several species of the genus Apodemus. We propose a subdivision of the species Dobrava-Belgrade virus into four related genotypes – Dobrava, Kurkino ...
Avsic-Zupanc, T. +13 more
core +1 more source
Journal of Medical Virology, Volume 97, Issue 8, August 2025.ABSTRACT Severe COVID‐19 is associated with increased prothrombotic and inflammatory responses, necessitating effective anticoagulation therapy. Novel oral anticoagulants (NOACs) are being explored as potential alternatives to low‐molecular‐weight heparin (LMWH).
Rubens Carmo Costa‐Filho +11 more
wiley +1 more source
Medical treatment of viral pneumonia including SARS in immunocompetent adult [PDF]
, 2004 Since no randomized controlled trials have been conducted on the treatment of viral pneumonia by antivirals or immunomodulators in immunocompetent adults, a review of such anecdotal experience are needed for the more rational use of such agents.
Cheng, VCC +4 more
core +1 more source
Treatment of hantavirus pulmonary syndrome [PDF]
Antiviral Research, 2008 Viruses in the genus Hantavirus can cause one of two serious illnesses when transmitted from rodents to humans: hemorrhagic fever with renal syndrome (HFRS) or hantavirus pulmonary syndrome (HPS). Of the two diseases, HPS is more severe with an approximate 40% mortality across the Americas.
Colleen B, Jonsson +2 more
openaire +2 more sources
Land Use Change and Infectious Disease Emergence
Reviews of Geophysics, Volume 63, Issue 2, June 2025.Abstract Major infectious diseases threatening human health are transmitted to people from animals or by arthropod vectors such as insects. In recent decades, disease outbreaks have become more common, especially in tropical regions, including new and emerging infections that were previously undetected or unknown. Even though there is growing awareness
M. Cristina Rulli +6 more
wiley +1 more source
Hantavirus in rodents in the United States: Temporal and spatial trends and report of new hosts
Ecosphere, Volume 16, Issue 3, March 2025.Abstract In North America, the rodent‐borne hantavirus pulmonary syndrome is predominantly caused by the Sin Nombre virus, typically associated with the deer mouse Peromyscus maniculatus. Utilizing data from the National Ecological Observatory Network (NEON) hantavirus program, we assessed factors that may influence the spatial and temporal ...
Francisca Astorga +4 more
wiley +1 more source
Pathogens, 2021 Background: With the current climate change crisis and its influence on infectious disease transmission there is an increased desire to understand its impact on infectious diseases globally.
Kirk Osmond Douglas +3 more
doaj +1 more source
Hantavirus-driven PD-L1/PD-L2 upregulation: An imperfect viral immune evasion mechanism [PDF]
, 2018 Viruses often subvert antiviral immune responses by taking advantage of inhibitory immune signaling. We investigated if hantaviruses use this strategy.
Abdelaziz, Mohammed O. +3 more
core +2 more sources